Twelve healthy subjects received high-voltage pulsed galvanic stimulation (115-475 V d.c.) delivered in separate treatments of 2, 32 and 128 pulses/s for 10 min at the subject's maximum tolerable voltage while calf muscle blood flow was measured by non-invasive Whitney strain-gauge venous occlusion plethysmography. 2. The high-voltage pulsed galvanic stimulation was administered with negative polarity by an intermittent mode of 30 s on, 30 s off. Measurements of calf muscle blood flow were made during each 30 s period when the stimulus was off. The effect of one 30 s maximum isometric contraction of the calf muscles on blood flow was used as a standard for evaluating the effectiveness of high-voltage pulsed galvanic stimulation on calf muscle blood flow.
INTRODUCTION
Electrical stimulation (ES) has been widely used by physical therapists for the purpose of increasing blood flow locally. Unfortunately, there have been relatively few studies designed specifically to assess the effectiveness of ES in elevating blood flow. It is difficult to assess the effect of ES on blood flow from the results of those studies because of the wide variation both in the protocols and characteristics of ES used, and the results have been inconsistent. For example, in studies on humans, those using a.c. ES have shown changes in blood flow [l, 21, but high-voltage pulsed galvanic stimulation (HVPGS, d.c.) administered in a variety of configurations of frequency, mode and intensity has not resulted in significant changes in blood flow [3-81. In contrast, studies of HVPGS in animal models (anaesthetized) have shown significant increases in muscle blood flow [9] . This latter conflict in results between HVPGS studies on animals and humans raises the question of whether the stimulus levels tolerable in conscious human subjects can effectively increase blood flow. It is clear that further well-designed studies of the effects of ES on tissue blood flow in humans are needed to assess its effectiveness and to justify its continued use for this purpose in the clinical setting.
It is also problematic that the methods used for monitoring blood flow have often been either inappropriate (laser Doppler flowmetry or photoplethysmography) [5] or limited to only qualitative assessment of changes in blood flow (ultrasonic Doppler flowmetry) [1, 3, 4, 6 , 8, 10, 111 . Electromagnetic flow meters, which do provide a quantitative measure of blood flow through large vessels, must be implanted surgically around the vessel and are only used in animal models. The most appropriate method for measuring the effect of ES on muscle or skin blood flow in humans is venous occlusion plethysmog-raphy [12] . It is a highly sensitive, non-invasive method that provides a quantitative measure of the changes in blood flow by measuring the change in the volume of the stimulated limb over time while venous drainage of the limb is temporarily (4 s) o d u d e d .
The purpose of this study was to investigate the effects of HVPGS, applied to calf muscle at an intensity adequate for stimulating muscle contractions, on calf muscle blood flow (BF,) as measured by venous occlusion plethysmography. Three different frequencies of current (2, 32 and 128 pulses/s) were used at the subject's maximum tolerated voltage level to determine if any increase in BF, occurs during HVPGS. In addition, the effect of a maximal isometric contraction of the calf muscles on BF, was assessed and was used as a standard of comparison to assess the effectiveness of HVPGS in increasing BF,.
Of particular importance to the success of this study was the combined use of the intermittent mode of HVPGS delivery with a duty cycle of 30 s on and 30 s off, and venous occlusion plethysmography which assessed calf blood flow at 15 s intervals. This allowed for two consecutive measures of BF, between each 30 s period of HVPGS during each 10 min treatment period. Previous protocol designs have only allowed for single assessments of muscle blood flow after completion of several minutes of stimulation. The present design allows us to follow the time course of BF, changes throughout baseline and stimulation periods.
METHODS

Subjects
Twelve healthy subjects, two men and 10 women, between the ages of 22 and 31 years were studied. They were screened for past and present history of cardiovascular, peripheral vascular or neuromotor disorders and for any conditions of pain, infection, bleeding or decreased sensation in the lower extremities. Smokers and diabetics were excluded. All subjects abstained from medications, including alcohol and caffeine, for at least 12 h before participation. Each subject's skin was examined to rule out lesions, rashes or breaks in the skin on the left leg, used in this study. All subjects gave their informed consent to the study, which was approved by the Institutional Review Board of Columbia Presbyterian Medical Center.
Measured parameters
The parameters monitored were heart rate (HR), mean arterial blood pressure (MABP) and BF,. All data were recorded on a chart recorder and via a computerized real-time data acquisition system for non-invasive autonomic nervous system assessment.
HR. This was monitored via an ECG and by an R-wave detector that produced a 2.5-5 V d.c. signal for the computer for each R-wave detected. The real-time of each R-wave was determined to millisecond accuracy by the clock on a LabMaster D/A, A/D converter (Scientific Solutions Inc.) and an IBM XT computer (IBM).
MABP. [17, and venous occlusion cuffs inflated to 45-55 mmHg and positioned proximal to the gauges. The computer initiated cuff inflation at the appropriate intervals and at the time of an R-wave, and terminated cuff inflation 4 s later. After cuff inflation, the computer sampled and recorded the output from the plethysmograph units exactly 100 ms after each consecutive R-way. The magnitude of BF, was assessed from the slope of the relationship between time lapsed (i.e. R-R interval between the second and third heart beats: independent variable) and the change in plethysmograph signal during that time (V d.c. proportional to BF,: dependent variable) and was expressed in ml min-l 100 ml-l of tissue [12] .
Preparation of subjects and application of HVPGS
Subjects were supine on a padded table. Their left leg was elevated above the table with foam blocks under the ankle and proximal to the knee. This is essential for good BF, measurements, as the limb must be elevated above the level of the heart for proper venous drainage after each BF, measurement is completed. In addition, there cannot be any pressure on the strain gauge (which would occlude the tubing) as would occur if the leg were lying on the table.
The active electrodes of the HVPGS units were secured in place on the posterior aspect of the calf. One was positioned at the mid-belly of the gastrocnemius muscle and the other approximately two thirds down the length of the leg from the popliteal crease at mid-line. The dispersal pad was placed on the posterior left thigh. All electrode pads were in even contact with the subject's skin and were secured with Velcro straps. The pneumatic venous occlusion cuff was then placed on the subject's left leg above the level of the superior border of the patella. The Whitney strain gauge [16] was positioned just distal to the proximal active electrode.
HVPGS can be applied in a variety of configurations. The variables include mode (reciprocate, continuous, intermittent), polarity, current frequency and voltage. The HVPGS used in this study was of intermittent mode with a duty cycle of 30 s on and 30 s off, negative polarity and a current frequency of 2, 32 and 128 pulses/s applied at the highest voltage tolerated by each subject. The treatment duration was 10 rnin for each current frequency. The selection of the intermittent mode was an important part of protocol design, since it allowed for two measures of BF, between each 30 s bout of stimulation, whereas use of the continuous mode does not allow for BF, measurements during the treatment period owing to movement artefact generated by the contracting muscles. Negative polarity was chosen because it had been reported [ 5 ] that it tended to cause greater increases (insignificant) in blood flow. The current frequencies of 2, 32 and 128 pulses/s spanned the range of frequencies available with the HVPGS unit used in this study (Intelect, model 550 Portable HVS; Chattanooga Corporation, Chattanooga, TN, U.S.A.) and commonly used in clinics. The maximum tolerated voltage was used because the magnitude of muscle contraction is directly related to voltage level and we wanted to assess the maximum BF, attainable at each current frequency used. Voltage tolerance is dependent on tissue impedance and pain threshold, and thus varies greatly between individuals. After the set-up was completed, but before the experiment was begun, the voltage was taken up to each subject's tolerance level at each of the three current frequencies both to allow each subject to experience ES and to give the investigator an estimation of the subject's perceived maximum voltage tolerance.
A maximum isometric contraction of the plantar flexor muscles was elicited by having the subject push against a vertical foot board (perpendicular to the table) while the ankle was in a neutral position of approximately 90 degrees. The subject was asked to maintain the isometric contraction throughout one 30 s period, to continue breathing normally throughout the manoeuvre, and to stabilize their body by grasping either side of the table. BF, was assessed after completion of the isometric contraction. This manoeuvre was practiced before the beginning of the experiment.
Protocol
All measurements on a subject were made in one session which lasted about 2 h. Since the set-up took at least 30 min, the subject had been resting supine for this amount of time before the protocol (depicted in Fig. 1 ) began. A 10 min period of quiet rest was followed by three paired baseline and treatment bouts which involved 2 min of baseline before and after 10 rnin of HVPGS treatment. Each of these treatment bouts was followed by a 6 min rest period. After the final HVPGS treatment and rest period, a final 2 rnin baseline was followed by the 30 s maximal isometric contraction. The effect of the maximal isometric contraction on BF, was monitored for the subsequent 2 min. To avoid possible problems due to the order of exposure to the current frequencies of 3, 32 and 128 pulses, the order was systematically rotated through the sjx possible variations with each variation used for two subjects, but in all experiments the isometric contraction was performed last. 
Data analysis
The mean MABP and BF, during each baseline and associated HVPGS treatment or post-isometric contraction period was determined. A paired t-test at the 5% level of significance was used to determine if there was a significant difference between baseline and associated treatment values of MABP and BF,. The paired t-test was chosen because it is a sensitive test that reduces the effects of inter-subject variability and is appropriate to protocol designs which compare two treatments (or baseline with treatment) in the same individuals [19] .
The change in BF, between baseline and associated treatment were determined for each subject. The relationship between the maximum tolerated voltage and the change in BF, was assessed for each treatment with linear regression analysis. Analysis of co-variance [20] was used to assess whether the slopes or the y-intercepts of the linear relationships for the treatments differed significantly.
RESULTS
The maximum tolerated voltage varied greatly between subjects (Fig. 2) . The voltage level tolerated for the frequency of 2 pulses/s, which caused isolated contractions, was always greater than for the frequencies of 32 or 128 pulses/s, which resulted in tetanic contraction of the muscle.
The BF, for the entire protocol is depicted in Fig. 1 for one representative subject. BF, increased during each HVPGS (2, 32 and 128 pulses/s) treatment in this subject.
The elevation in BF, was achieved early during the stimulus period and did not increase further during the 10 min period of treatment. Note also that at frequencies of 2 and 32 pulses/s, the first BF, measurement after each 30 s of stimulation was higher than the second, demonstrating how rapidly BF, declines when stimulation has stopped. After HVPGS (see Fig. 1) or the maximal isometric contraction ended, the elevation in BF, achieved during The mean BF, for the baselines and associated treatments are shown for all subjects and treatments in Table 1 . Significant increases (paired t-tests) in BF, resulted from the maximal isometric contraction ( P < 0.001) and NVPGS delivered at frequencies of 2 and 128 pulses/s (P<0.01), but not from HVPGS at a frequency of 32 pulses/s (P> 0.05; six of 12 subjects showed no increase in BF, for this treatment). The maximal isometric contraction caused large increases in BF, in every subject: absolute increases of 3.48-19.05 (mean f SD 13.24k4.26) ml min-' 100 ml-I of tissue, percentage increases of 50-7 19% (mean increase = 412.52%). HVPGS resulted in small to moderate increases in BF, in most tests (i.e. 22 of 36 tests; absolute increases of 0.05-5.3 ml min-' 100 mI-' of tissue; percentage increases of 2-158%). Of the 14 cases where there was no increase in BF,, nine are attributable to three subjects which were intolerant of high voltage levels at all frequencies used, and the other five were instances of subjects intolerant of high voltage levels at the higher frequencies (32 pulses/s, six subjects; 128 pulses/s, five subjects). MABP was elevated by the maximal isometric contraction (meanfsn 3.58f2.35 mmHg; P <0.05), but was unaffected by HVPGS ( P > 0.05).
The large between-subject variation in maximum tolerated voltage allowed us to assess the relationship between voltage level and the magnitude of the change in BF,. There were clear positive correlations (Fig. 3) between the maximal tolerated voltage and the resulting change in BF, for each frequency: 2 pulses/s: y=O.O11449x+ -1.98, r=0.69; 32 pulses/s: y=O.O13x+ -0.962, r=0.45 (includes only the six subjects showing increased BF,); 128 pulses/s: y=0.012x+ -1.46, r=0.88). Note that the reason that the frequency of 32 pulses/s did not show a significant increase in BF, in the paired t-test was that six of 12 subjects showed either no change or a slight decline in BF, at this frequency.
Analysis of co-variance indicated that the slopes of the relationships for the frequencies 2 and 128 pulses/s are not significantly different, but they do have different yintercepts. These relationships differed for each frequency with the threshold voltage (voltage level above which BF, increases) being lower for 128 pulsesls (122 V d.c.) than for 2 pulses/s (173 V d.c.). At any given voltage level between 100 and 240 V d.c. (tolerated for all frequencies), the increase in BF, was greatcr at frequencies of 32 and 128 pulses/s than at 2 pulses/s.
A comparison of the relationships (between voltage and BF,) observed at 2 and 128 pulses/s indicated that over the range of 100-240 V d.c. tolerated at both frequencies, BF, was increased more by a frequency of 128 pulses/s than by 2 pulses/s at any given voltage level. In six of the 12 subjects, the maximum tolerated voltage at a frequency of 2 pulses/s was 300-500 V d.c., but only three of the six subjects showed increases in BF, significantly larger than those observed for lower voltage levels at all three frequencies used. Thus, although there was a tendency for the elevations in BF, to increase with increased voltage level for any frequency used, and higher voltages were better tolerated at a frequency of 2 pulses/s than at 128 pulses/s only three (50"/0) of the six subjects tolerating the higher voltage levels at a frequency of 2 pulse.+ actually demonstrated a significantly higher BF, than had been observed at 128 pulses/s.
DISCUSSION
The results of the present study show four important findings. First, that there is large between-subject variability in the maximum voltage tolerated at any given frequency of HVPGS (Fig. 2) , but that all individuals tolerated a higher voltage level at a frequency of 2 pulses/s than at 32 or 128 pulses/s. Secondly, HVPGS delivered at the subject's maximum tolerated voltage did increase BF, in the majority (22 of 36) of treatments (Table 1) . Thirdly, the presence of the between-subject variability allowed us to demonstrate that positive linear correlations exist between the voltage used for delivering the HVPGS and the magnitude of the increase in BF,, and that the relationships are somewhat different for each frequency used (Fig. 3) . Fourthly, all instances in which no increase in BF, was observed occurred in individuals intolerant of high voltages 'at the frequency used for that particular treatment. Some individuals were intolerant of high voltage levels at all three frequencies used in this study. Of the 14 treatment periods in which there was no increase in BF, (i.e. change in BF, < 0.5 ml min-I 100 ml-I of tissue), nine are attributable to three subjects (indicated by asterisks in Table 1) were intolerant of voltages above 170 V d.c. for the higher frequencies of 32 (ti = 3) and 128 ( IZ = 2) pulses/s. Furthermore, the increase in BF, was not attributable to increased MABP, since MABP was unaffected by HVPGS. It is clear from these results that blood flow can be increased in muscle tissue through the proper application of HVPGS and that the lack of increased blood flow in response to HVPGS was restricted to individuals who were intolerant of high voltage levels. Furthermore, correlations between voltage level and the magnitude of increased BF, (Fig. 3) indicate that it is possible to develop criteria for determining whether HVPGS can be effective for increasing tissue blood flow in any given subject. When its use is indicated, these correlations can be used to detcrmine the configuration of the HVPGS which will be maximally effective for each patient. To achieve this level of expertise in the application of HVPGS, further studies need to be carried out to determine the correlations between voltage level and magnitude of change in blood flow for the many possible configurations of HVPGS treatment.
There have been relatively few studies on the effects of HVPGS on blood flow, and their results show substantial conflict. Rawlings [7] used the same methodology as the present study, but administered HVPGS of positive polarity and at levels which did not result in muscle contractions, and observed no significant change in BF,. This suggests that increases in blood flow are associated with muscle contraction and not the stimulus per se. Other findings supportive of this conclusion are from studies of skin blood flow in response of HVPGS. Hecker et al. [5] found no change in superficial blood flow (asszssed by photoplethysmography, which reaches the top 2 mm of skin) in response to HVPGS delivered in continuous pulsed mode at positive and negative polarity and frequencies of 2, 8, 32, 64 and 128 pulses/s at the subject's maximum tolerated voltage level. Alon [4] found no change in blood flow in the posterior tibia1 artery in response to HVPGS (frequency 80 pulses/s) administered to the posterior thigh at voltages too low to cause muscle contractions.
Loze (G. Loze, unpublished work) and Fields & Currier [lo] found no change in blood flow through the popliteal artery, as assessed from ultrasonic Doppler flowmetry, in response to HVPGS administered to the gastrocnemius muscle in reciprocal mode at frequencies of 4, 15, 30 and 80 pulses/s (polarity not stated) at the subject's maximum tolerated voltage level. Walker et al. [8] likewise observed no change in blood flow at the popliteal artery, as assessed by an ultrasonic Doppler flowmeter, in response to HVPGS of the same configuration (frequency 30 pulses/s) administered to induce muscle contraction of 10 and 30% of maximal voluntary contraction in the gastrocnemius muscle. The lack of observed increase in blood flow in these studies could be due to the ultrasonic Doppler flowmeter not being sensitive enough to detect the small changes in blood flow which we observed using venous occlusion plethysmography. Besides being a less sensitive measure of blood flow, the ultrasonic Doppler flowmeter measures provide only qualitative (percentage) changes rather than the sensitive quantitative measure provided by venous occlusion plethysmography.
Currier et ril. [2] reported an increase in blood flow through the popliteal artery, as assessed using an ultrasonic Doppler flowmeter, in response to a.c. ES delivered to the calf muscle at 10 and 30% of the subjects' maximal voluntary contraction using a surged mode with a duty cycle of 12 s on and 8 s off. The reported increase in blood flow was only apparent between the control group and the ES group which included different individuals. A significant increase in blood flow was not demonstrated between the pre-stimulation period and the stimulation period in the same individuals. In a similar study by the same group [l], blood flow in the ipsilateral finger was found to decrease in response to a.c. ES delivered to the calf muscle. This study suffers from the same problems in protocol design as the previous one in that differences were demonstrated only between the control group and treatment groups. No significant change in blood flow was demonstrated between pre-stimulation measurements and measurements made during application of the a.c. ES.
An excellent study by Mohr et ul. [9] , which used anaesthetized rats as subjects, demonstrated that HVPGS caused increases in femoral artery blood flow. These investigators used an ultrasonic Doppler flowmeter equipped with a probe which was surgically implanted around the femoral artery and thus not as prone to the artefacts related to vessel targeting which afflict the pencil probes held to the skin surface. This Doppler probe preparation can also be empirically calibrated before and after the study. HVPGS was applied to the leg using 90 V d.c., continuous mode, negative polarity at frequencies of 1,20, SO and 120 pulses/s. Femoral artery blood flow was elevated at all frequencies, but was greatest at 20 pulses/s.
In subsequent protocols that applied HVPGS at 90 V d.c. and 20 pulses/s, it was determined that (a) negative polarity was more effective than positive polarity, although both increased femoral artery blood flow, (b) the voltage threshold for stimulating an increase in femoral artery blood flow was between 40 and 60 V d.c. and coincided with the elicitation of muscle contraction, (c) after reaching the threshold the magnitude of the increase in femoral artery blood flow increased with each increase in voltage level, and (d) stimulating one leg did not alter femoral artery blood flow in the ipsilateral unstimulated limb. The results of this well-designed study on an animal model corroborate the trends observed in the present study on humans, but clearly the voltage levels needed to invoke a change in blood flow in the rat were substantially lower. Furthermore, the fact that the rats were anaesthetized during the treatments disallowed assessment of whether the voltage levels required to stimulate increased femoral artery blood flow were tolerable to an alert unanaesthetized rat. This is an important concern considering the dearth of observations of elevated blood flow in studies on human subjects.
For effective use of HVPGS to increase blood flow, clinicians clearly must weigh the advantages of using the higher frequencies (32 and 128 pulses/s) because of their lower threshold voltage against the advantage of the higher voltage levels tolerated at a frequency of 2 pulses/s. The rules of thumb which can be implied from the findings of the present study are: (a) that the patient must be able to tolerate voltage levels greater than 200 V d.c. at a frequency of 2 pulses/s, and greater than 170 V d.c. at 32 or 128 pulses/s, and (b) using the frequency of 2 pulses/s is advantageous for increasing blood flow only in subjects who tolerate voltage levels above 300 V d.c., and then only in about 50% of the subjects. Furthermore, even in subjects showing maximal increases in calf muscle blood flow at each treatment level, the increases were only 17-51% that caused by the maximal isometric contraction.
Additional studies need to be carried out to determine the most effective frequency, polarity, mode and voltage level for increasing blood flow using HVPGS treatment in clinical settings. With such information a stepwise procedure for determining the most effective configuration of HVPGS treatment could be set up for individual subjects, regardless of their differences in tolerance. What remains unclear, and therefore needs further study, is the degree to which increasing blood flow per se is helpful therapy for injured or oedematous tissue or for the prevention of deep vein thrombosis. The observations of the present study, that HVPGS increases muscle blood flow and that the magnitude of this increase is measurable, provides the essential tools for evaluating whether it is therapeutically useful to increase muscle blood flow in the treatment of these conditions.
